Consolidated Balance Sheet

STELLA PHARMA CORPORATION - Filing #7320249

Concept As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
Consolidated balance sheet
Balance sheet
Assets
Non-current assets
Property, plant and equipment
Buildings, net
5,705,000 JPY
7,145,000 JPY
Property, plant and equipment
81,527,000 JPY
102,874,000 JPY
Intangible assets
52,548,000 JPY
61,667,000 JPY
Software
4,280,000 JPY
7,706,000 JPY
Intangible assets
Patent right
47,780,000 JPY
53,341,000 JPY
Investments and other assets
Investment securities
JPY
302,743,000 JPY
Other
18,722,000 JPY
20,955,000 JPY
Long-term prepaid expenses
38,532,000 JPY
48,077,000 JPY
Investments and other assets
57,255,000 JPY
371,776,000 JPY
Non-current assets
191,330,000 JPY
536,318,000 JPY
Current assets
Cash and deposits
2,052,704,000 JPY
2,710,301,000 JPY
Securities
300,943,000 JPY
JPY
Accounts receivable - trade
76,227,000 JPY
59,288,000 JPY
Work in process
1,012,691,000 JPY
849,567,000 JPY
Prepaid expenses
40,633,000 JPY
39,488,000 JPY
Raw materials and supplies
2,988,000 JPY
2,192,000 JPY
Other
42,525,000 JPY
43,059,000 JPY
Current assets
3,629,291,000 JPY
3,792,734,000 JPY
Assets
3,820,622,000 JPY
4,329,053,000 JPY
Liabilities and net assets
Non-current liabilities
988,010,000 JPY
1,154,965,000 JPY
Long-term borrowings
773,292,000 JPY
933,300,000 JPY
Current liabilities
455,599,000 JPY
421,585,000 JPY
Accounts payable - other
202,340,000 JPY
196,059,000 JPY
Accrued expenses
4,428,000 JPY
5,075,000 JPY
Deposits received
2,786,000 JPY
4,022,000 JPY
Liabilities
1,443,610,000 JPY
1,576,550,000 JPY
Shareholders' equity
2,370,053,000 JPY
2,742,357,000 JPY
Share capital
2,938,110,000 JPY
3,300,417,000 JPY
Capital surplus
195,722,000 JPY
220,794,000 JPY
Retained earnings
-763,749,000 JPY
-778,824,000 JPY
Treasury shares
-30,000 JPY
-30,000 JPY
Share acquisition rights
6,959,000 JPY
10,144,000 JPY
Net assets
2,370,053,000 JPY
195,722,000 JPY
195,722,000 JPY
-30,000 JPY
-763,749,000 JPY
6,959,000 JPY
JPY
2,938,110,000 JPY
2,377,012,000 JPY
-763,749,000 JPY
3,300,417,000 JPY
-778,824,000 JPY
JPY
2,752,502,000 JPY
220,794,000 JPY
10,144,000 JPY
220,794,000 JPY
-30,000 JPY
2,742,357,000 JPY
-778,824,000 JPY
1,908,276,000 JPY
JPY
-2,636,930,000 JPY
JPY
3,808,276,000 JPY
JPY
3,079,623,000 JPY
-2,636,930,000 JPY
1,908,276,000 JPY
3,079,623,000 JPY
Liabilities and net assets
3,820,622,000 JPY
4,329,053,000 JPY
Liabilities
Current liabilities
Current portion of long-term borrowings
160,008,000 JPY
160,008,000 JPY
Income taxes payable
9,980,000 JPY
6,330,000 JPY
Provisions
Provision for bonuses
365,000 JPY
1,020,000 JPY
Non-current liabilities
Net assets
Shareholders' equity

Talk to a Data Expert

Have a question? We'll get back to you promptly.